当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析

迈威生物-U

(688062)

  

流通市值:80.26亿  总市值:157.08亿
流通股本:2.04亿   总股本:4.00亿

迈威生物-U(688062)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-6.00亿元,每股收益-1.50元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益94558.25万元,未分配利润-539292.88万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产452708.93万元,负债358150.68万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入565,838,248.14101,165,449.1444,788,452.49199,781,622.22
营业总成本1,164,855,191.83671,700,790.36336,094,745.31,259,798,298.88
其他经营收益
营业利润-582,936,935.76-552,442,829.55-291,020,952.63-1,043,479,690.64
利润总额-582,677,606.59-552,175,797.82-292,403,466.37-1,047,471,478.76
净利润-599,596,769.92-552,229,971.82-292,457,640.37-1,046,564,705.48
每股收益
其他综合收益2,664.16-42,444.07-41,128.07278,847.66
综合收益总额-599,594,105.76-552,272,415.89-292,498,768.44-1,046,285,857.82
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,945,024,390.541,880,685,962.881,658,452,655.051,705,180,931.68
非流动资产:
非流动资产合计2,582,064,872.562,587,873,276.492,532,903,760.482,570,327,921.37
资产总计4,527,089,263.14,468,559,239.374,191,356,415.534,275,508,853.05
流动负债:
流动负债合计2,158,018,752.662,083,832,217.971,756,407,829.541,541,715,656.18
非流动负债:
非流动负债合计1,423,488,042.11,381,148,199.931,171,625,780.631,178,015,148.54
负债合计3,581,506,794.763,464,980,417.92,928,033,610.172,719,730,804.72
所有者权益(或股东权益):
归属于母公司股东权益合计761,099,851.75818,070,486.771,277,151,626.391,568,877,364.27
股东权益合计945,582,468.341,003,578,821.471,263,322,805.361,555,778,048.33
负债和股东权益合计4,527,089,263.14,468,559,239.374,191,356,415.534,275,508,853.05
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计862,766,573.45554,782,686.3159,382,060.81365,063,601.18
经营活动现金流出小计965,798,043.04588,707,146.94275,998,801.981,321,507,231.36
经营活动产生的现金流量净额-103,031,469.59-33,924,460.63-216,616,741.17-956,443,630.18
投资活动产生的现金流量:
投资活动现金流入小计182,405,570.1242,175,778.4532,155,778.45385,447,416.86
投资活动现金流出小计383,466,693.34142,401,820.0687,133,137.92677,001,577.43
投资活动产生的现金流量净额-201,061,123.22-100,226,041.61-54,977,359.47-291,554,160.57
筹资活动产生的现金流量:
筹资活动现金流入小计1,685,840,0001,167,140,000751,840,0003,608,373,290.69
筹资活动现金流出小计1,168,592,549.64871,776,140.15570,707,471.022,776,675,458.47
筹资活动产生的现金流量净额517,247,450.36295,363,859.85181,132,528.98831,697,832.22
汇率变动对现金及现金等价物的影响-1,291,825.48-153,575.87-138,837.15232,889
现金及现金等价物净增加额211,863,032.07161,059,781.74-90,600,408.81-416,067,069.53
期末现金及现金等价物余额1,439,429,197.31,388,625,946.971,136,965,756.421,227,566,165.23
补充资料:
现金及现金等价物的净增加额-161,059,781.74--416,067,069.53
最新报告期:2025-11-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华西证券孙子豪,崔文亮-2.09-1.180.092025-11-27
东方证券伍云飞,傅肖依-1.84-1.64-0.732025-11-04
野村东方国际证券孔令岩,肖鸿德-1.81-0.610.032025-10-31
国投证券连国强-1.69-1.55-0.432025-10-31
TOP↑